Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271461 (2-(6-((1H-indol-1-yl)sulfonyl)-4-hydroxy-1-methyl-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet  | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.83E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271496 (2-(7-(2-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.02E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271472 (2-(7-(2,5-difluorophenoxy)-4-hydroxy-1-methyl-2-ox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.26E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271478 (2-(7-(4-chloro-3-fluorophenoxy)-4-hydroxy-1-methyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.02E+4 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271489 (2-(4-hydroxy-7-(4-methoxyphenoxy)-1-methyl-2-oxo-1...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.95E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271459 (2-(1-(cyclopropylmethyl)-4-hydroxy-2-oxo-7-phenoxy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271460 (2-(4-hydroxy-1-methyl-2-oxo-6-phenoxy-1,2-dihydroq...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.00E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271468 (2-(7-(2,4-difluorophenoxy)-4-hydroxy-1-methyl-2-ox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.92E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271480 (2-(7-(2-chloro-5-fluorophenoxy)-4-hydroxy-1-methyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.85E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271485 (2-(7-(2,6-dichlorophenoxy)-4-hydroxy-1-methyl-2-ox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.63E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271486 (2-(7-(3,4-dichlorophenoxy)-4-hydroxy-1-methyl-2-ox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.56E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271490 (2-(4-hydroxy-7-(3-methoxyphenoxy)-1-methyl-2-oxo-1...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.26E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271492 (2-(6-fluoro-4-hydroxy-1-methyl-2-oxo-7-phenoxy-1,2...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.89E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271473 (2-(7-(3-chloro-2-fluorophenoxy)-4-hydroxy-1-methyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.75E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271475 (2-(7-(5-chloro-2-fluorophenoxy)-4-hydroxy-1-methyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.18E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271479 (2-(7-(3-chloro-5-fluorophenoxy)-4-hydroxy-1-methyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.35E+4 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271483 (2-(7-(2,3-dichlorophenoxy)-4-hydroxy-1-methyl-2-ox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.97E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271474 (2-(7-(4-chloro-2-fluorophenoxy)-4-hydroxy-1-methyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.75E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271481 (2-(7-(2-chloro-4-fluorophenoxy)-4-hydroxy-1-methyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.51E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271491 (2-(4-hydroxy-7-(2-methoxyphenoxy)-1-methyl-2-oxo-1...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.85E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271463 (2-(4-hydroxy-1-methyl-6-(naphthalen-2-yloxy)-2-oxo...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.52E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271466 (2-(7-(4-chlorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.10E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271469 (2-(7-(2,6-difluorophenoxy)-4-hydroxy-1-methyl-2-ox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.83E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271477 (2-(7-(2-chloro-3-fluorophenoxy)-4-hydroxy-1-methyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9.53E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271498 (2-(7-(4-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.92E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271462 (2-(4-hydroxy-1-methyl-7-(naphthalen-2-yloxy)-2-oxo...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.63E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271465 (2-(7-(3-chlorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.24E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271467 (2-(7-(2,3-difluorophenoxy)-4-hydroxy-1-methyl-2-ox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.03E+4 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271476 (2-(7-(2-chloro-6-fluorophenoxy)-4-hydroxy-1-methyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9.23E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271482 (2-(7-(3-chloro-4-fluorophenoxy)-4-hydroxy-1-methyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.02E+4 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271495 (2-(4-hydroxy-1-methyl-2-oxo-7-(pyridin-4-yloxy)-1,...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.89E+4 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271470 (2-(7-(3,4-difluorophenoxy)-4-hydroxy-1-methyl-2-ox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.16E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271484 (2-(7-(2,4-dichlorophenoxy)-4-hydroxy-1-methyl-2-ox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.15E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271488 (2-(7-(2,5-dichlorophenoxy)-4-hydroxy-1-methyl-2-ox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.25E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271494 (2-(1-(cyclopropylethyl)-4-hydroxy-2-oxo-7-phenoxy-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.34E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271497 (2-(7-(3-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.61E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271499 (2-(7-(2-chlorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.60E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271458 (2-(4-hydroxy-1-methyl-2-oxo-7-phenoxy-1,2-dihydroq...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.35E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271464 (2-(6-(benzhydryl(methyl)carbamoyl)-4-hydroxy-1-met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.02E+4 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271487 (2-(7-(3,5-dichlorophenoxy)-4-hydroxy-1-methyl-2-ox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.02E+4 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271493 (2-(4-hydroxy-1-methyl-2-oxo-7-(2-(trifluoromethoxy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.06E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Hypoxia-inducible factor 1-alpha (Homo sapiens (Human)) | BDBM271471 (2-(7-(3,5-difluorophenoxy)-4-hydroxy-1-methyl-2-ox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.28E+3 | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (... | US Patent US10065928 (2018) BindingDB Entry DOI: 10.7270/Q2DB83WQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
